Chemical synthesis and immunological evaluation of cancer vaccines based on ganglioside antigens and α-galactosylceramide-Reference-Cited by-同舟云学术

Chemical synthesis and immunological evaluation of cancer vaccines based on ganglioside antigens and α-galactosylceramide

Published:2024 Issue:8 Volume:15 Page:2718-2728
ISSN:2632-8682
Container-title:RSC Medicinal Chemistry
language:en
Short-container-title:RSC Med. Chem.

Author:

Romanò Cecilia¹^ORCID,Jiang Hao¹,Tahvili Sahar¹,Wei Peng¹^ORCID,Keiding Ulrik B.¹,Clergeaud Gael²,Skovbakke Sarah Line³^ORCID,Blomberg Anne Louise³,Hafkenscheid Lise³,Henriksen Jonas R.²^ORCID,Andresen Thomas L.²,Goletz Steffen³^ORCID,Hansen Anders E.²,Christensen Dennis⁴,Clausen Mads H.¹^ORCID

Affiliation:

1. Center for Nanomedicine & Theranostics, Department of Chemistry, Technical University of Denmark, Kemitorvet 207, 2800 Kgs. Lyngby, Denmark

2. Department of Health Technology, Section for Biotherapeutic Engineering and Drug Targeting, Technical University of Denmark, Ørsteds Plads, 2800 Kgs Lyngby, Denmark

3. Department of Biotechnology and Biomedicine, Section for Medical Biotechnology, Biotherapeutic Glycoengineering and Immunology, Technical University of Denmark, Søltofts Plads, 2800 Kgs Lyngby, Denmark

4. Adjuvant Systems Research & Development, Croda Pharma, 2800 Lyngby, Denmark

Abstract

iNKT cells – often referred to as the “Swiss Army knife” of the immune system – have emerged as central players in cancer vaccine therapies.

Funder

China Scholarship Council

Lundbeck Foundation

Novo Nordisk Fonden

European Commission

Danmarks Frie Forskningsfond

Danmarks Tekniske Universitet

Publisher

Royal Society of Chemistry (RSC)